Efficacy and Safety of the fourth dose of mRNA COVID-19 Vaccine in healthy volunteers: An observational study.

Not Applicable

• Conditions: Healthy Volunteers

• Registration Number: JPRN-UMIN000048653
• Lead Sponsor: Kobe City Medical Center General Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-08-12
• Study Completion: 2023-08-31
• Last Update Posted: 20 November 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Not provided

Exclusion Criteria

1) Those deemed inappropriate for participation in the study by the investigator 2) Patients with a history of or coexisting with immunosuppressive medication, autoimmune diseases (systemic lupus erythematosus, Sjogren's syndrome, dermatomyositis/polymyositis, mixed connective tissue disease, systemic scleroderma, rheumatoid arthritis, polymyalgia rheumatica, psoriatic arthritis, spondyloarthritis and its related diseases, vasculitis syndrome, inflammatory bowel disease, Guillain-Barre syndrome, neuromyelitis optica) Multiple sclerosis, neuromyelitis optica). 3) Patients with a history of COVID-19 4) Inability to communicate

Study & Design

• Study Type: Observational
• Study Design: Not specified